Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...

Cryptococcal Meningitis

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...

Development of the Oral Microbiota

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.

The Journal of antimicrobial chemotherapy·2015

Same author

He's malnourished - admit him to the nutrition unit and feed him up!

Malawi medical journal : the journal of Medical Association of Malawi·2014

Same author

A 6 year-old boy was referred from a district hospital with congestive cardiac failure.

Malawi medical journal : the journal of Medical Association of Malawi·2014

Same author

The making of a doctor.

Malawi medical journal : the journal of Medical Association of Malawi·2013

Same author

Tricuspid endocarditis, in a 12 year old girl with a previously normal heart.

Malawi medical journal : the journal of Medical Association of Malawi·2013

Same author

Endomyocardial fibrosis: the first report from Malawi.

Paediatrics and international child health·2012

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Systematic review: neonatal meningitis in the developing world.

J S Furyk¹, O Swann, E Molyneux

¹James Cook University, School of Public Health, Tropical Medicine and rehabilitation sciences, Townsville, Australia. Jeremy_Furyk@health.qld.gov.au

Tropical Medicine & International Health : TM & IH

|March 15, 2011

Summary

This summary is machine-generated.

Neonatal meningitis is a major global health issue, particularly in developing nations where mortality rates are significantly higher. Understanding regional pathogen differences is crucial for effective treatment strategies.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Related Experiment Videos

Last Updated: Jun 3, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

Area of Science:

Neonatal infectious diseases
Global public health
Microbiology

Background:

Neonatal meningitis poses a significant global health burden, with higher mortality in developing countries (40-58%) compared to developed nations (10%).
Existing research predominantly originates from high-income countries, potentially overlooking critical differences in disease epidemiology and causative agents in resource-limited settings.

Purpose of the Study:

To highlight the disparities in neonatal meningitis epidemiology and causative pathogens between developed and developing countries.
To inform the selection of appropriate empiric antibiotic therapy based on local data and resource availability.

Main Methods:

Comparative analysis of existing literature focusing on neonatal meningitis prevalence and etiology.
Review of pathogen profiles from cerebrospinal fluid cultures in diverse geographical settings.

Main Results:

Significant differences in the spectrum of pathogens causing neonatal meningitis are observed between developed and developing countries.
While Group B Streptococcus (GBS) and Escherichia coli are common in developed nations, developing countries show varied results, including other Gram-negative bacteria, Listeria, and Gram-positive organisms.

Conclusions:

Empiric antibiotic choices for neonatal meningitis must consider local epidemiological data, resistance patterns, and drug availability.
Further research is needed to address knowledge gaps, explore adjuvant therapies, and improve outcomes in resource-limited settings.